MGMT and brain cancer: For example, brain cancers that lose activity of the O-6-methylguanine-DNA methyltransferase (MGMT) enzyme, which can directly reverse O-6 adducts, are more sensitive to the DNA-methylating drug temozolomide (TMZ) [29].